5037 |
Case 2: Mitral Regurgitation - Different Approaches to the Same Problem? |
Anthony Yiu Tung Wong |
Apr. 27. 19 |
5036 |
Bifurcation Lesion |
Junya Shite |
Apr. 27. 19 |
5035 |
Case 1: TAVR for Pure AR - Indication and Device |
Jian (James) Ye |
Apr. 27. 19 |
5034 |
Durability of TAVR vs. SAVR: Pathology Insights |
Aloke V. Finn |
Apr. 27. 19 |
5033 |
Cerebral Protection During TAVR: Why and How? |
Alan C. Yeung |
Apr. 27. 19 |
5032 |
Optimal Antithrombotics After TAVR: Ongoing Trials |
Duk-Woo Park |
Apr. 27. 19 |
5031 |
Can Angio-FFR Change Our Cath Lab Practice? |
Yoshinobu Onuma |
Apr. 27. 19 |
5030 |
Diffuse Tandem Lesion |
Hitoshi Matsuo |
Apr. 27. 19 |
5029 |
Prognosis of Discordant Lesion Between FFR and Hyperemia Free Indexes |
Jung-Min Ahn |
Apr. 27. 19 |
5028 |
Hyperemia Free Indexes: Algorithms, Diagnostic and Prognostic Performance |
Hitoshi Matsuo |
Apr. 27. 19 |